G. Olsson, N. White, J. Hjalten, and C. Ahlm, ) and Concomitant Hantavirus in Northern Sweden, Vector-Borne and Zoonotic Diseases, vol.5, issue.4, pp.315-338, 2005.
DOI : 10.1089/vbz.2005.5.315

. Hantavirus-erkrankungen, Deutliche Zunahme zu Beginn des Jahres Available from: http://www.rki.de/cln_049, Epid Bull, vol.14, p.120, 2007.

R. Ulrich, H. Meisel, M. Schütt, J. Schmidt, A. Kunz et al., Epidemiology of hantavirus infections in Germany, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, vol.47, issue.7, pp.661-670, 2004.
DOI : 10.1007/s00103-004-0858-8

P. Kimmig, R. Silva-gonzalez, H. Backe, S. Brockmann, R. Oehme et al., Epidemiologie von Hantaviren in Baden-W??rttemberg, Das Gesundheitswesen, vol.63, issue.2, pp.107-119, 2001.
DOI : 10.1055/s-2001-10961

L. Zöller, M. Faulde, H. Meisel, B. Ruh, P. Kimmig et al., Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay, European Journal of Clinical Microbiology & Infectious Diseases, vol.167, issue.4, pp.303-315, 1995.
DOI : 10.1007/BF02116523

A. Mailles, A. Sin, M. Ducoffre, G. Heyman, P. Koch et al., Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, E050721.4. Available from, pp.50721-50725, 2005.

L. Baden-wuerttemberg, Häufung von Hantavirus-Erkrankungen in Baden-Württemberg, Landesgesundheitsamt informiert über die Hintergründe. 27.04, pp.296-300, 2007.

J. Lindenbaum, W. Greenough, and M. Islam, Antibiotic therapy of cholera, Bull World Health Organ, vol.36, issue.6, pp.871-83, 1967.

D. Sack, S. Islam, H. Rabbani, and A. Islam, Single-Dose Doxycycline for Cholera, Antimicrobial Agents and Chemotherapy, vol.14, issue.3, pp.462-466, 1978.
DOI : 10.1128/AAC.14.3.462

D. Saha, W. Khan, M. Karim, H. Chowdhury, M. Salam et al., Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial, The Lancet, vol.366, issue.9491, pp.1085-93, 2005.
DOI : 10.1016/S0140-6736(05)67290-X

N. Crowcroft, Cholera: current epidemiology, Commun Dis Rep CDR Rev, vol.4, issue.13, pp.157-164, 1994.

J. Acar and F. Goldstein, Consequences of Increasing Resistance to Antimicrobial Agents, Clinical Infectious Diseases, vol.27, issue.s1, 1998.
DOI : 10.1086/514913

B. Krishna, A. Patil, and M. Chandrasekhar, Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100, issue.3, pp.224-230, 2006.
DOI : 10.1016/j.trstmh.2005.07.007

P. Garg, S. Sinha, R. Chakraborty, S. Bhattacharya, G. Nair et al., Emergence of Fluoroquinolone-Resistant Strains of Vibrio cholerae O1 Biotype El Tor among Hospitalized Patients with Cholera in Calcutta, India, Antimicrobial Agents and Chemotherapy, vol.45, issue.5, pp.1605-1611, 2001.
DOI : 10.1128/AAC.45.5.1605-1606.2001

D. Saha, M. Karim, W. Khan, S. Ahmed, M. Salam et al., Single-Dose Azithromycin for the Treatment of Cholera in Adults, New England Journal of Medicine, vol.354, issue.23, pp.2452-62, 2006.
DOI : 10.1056/NEJMoa054493

R. Guerrant, 2500-2. back to top A large outbreak of cryptosporidiosis in western Ireland linked to public water supply: a preliminary report H Pelly (heidi.pelly@mailn.hse.ie) 1 , M Cormican, N Engl J Med, vol.354, issue.23 2, 2006.